ASND
ASCENDIS PHARMA
Health Care·Biotechnology·DENMARK
$270.56
MCap $17.7B
as of 2026-09-04
Total
B10w
Fund
C9w
Quant
B1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
+0.19
Sentiment 29.3%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$270.56
Adaptive Mean
$269.44
+1.12 vs mean
Adaptive σ
2.96
MIDOS BB
$263.53 – $275.35
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+1.14
ROE
118.8%
Z —
Rev Gr
114.7%
Z +0.92
EPS Gr
—
Z +0.09
OPM Gr
113.3%
Z +0.40
FCF Yld
0.1%
Z +0.09
EPS Surp
0.2%
Z +4.59
EPS 3mo Δ
—
Z +0.73
Fwd P/E
29.02
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
16.83
Q6M
1.72
Q12M
5.00
MA 30/100
1.036
Bullish (MA30 > MA100)
α (Jensen)
1.0137
β (12M)
0.26
σ (12M)
0.371
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
98%
Q Percentile
79%
Divergence
+19.2
Tier
RELOAD — ACT
Fundamentals ahead of momentum.
Kirkpatrick RS & Persistence
RS
-0.1
RS Pctl
60%
RS Decile
D6
Persistence
10w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.